A NON-endemic spread of monkeypox has been reported in multiple countries – a phenomenon that has never happened before. The Centers for Disease Control and Prevention and the World Health Organization are developing plans for potential outbreaks – what are the 101s on this disease for healthcare providers?

The GameChanger 
Most cases of monkeypox are self-limiting, but death rates up to 10% have been reported, particularly in children and immunosuppressed patients. Treatment options for monkeypox exist but have not been evaluated in large studies to prove efficacy or safety.  

Show Segments 
00:00 – Introductions 
01:24 – Monkeypox Background  
08:29 – Monkeypox Presentation  
09:32 – Combating & Treating Monkeypox 
21:21 – Closing Remarks 

 
Host
Geoff Wall, PharmD, BCPS, FCCP, CGP 
Professor of Pharmacy Practice, Drake University 
Internal Medicine/Critical Care, UnityPoint Health 

References and resources:

• CDC. Monkeypox and Smallpox Vaccine Guidance. 
• WHO. Multi-country monkeypox outbreaks in non-endemic countries. 
• Clinical features and management of human monkeypox: a retrospective observational study in the UK.

Redeem your CPE or CME credit

• CPE (Pharmacist)
• CME (Physician)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) 

• Pharmacists: Get a Membership 
• Prescribers: Get a Membership 

Continuing Education Information:
Learning Objectives:
1. Describe the symptoms and signs of monkeypox
2. Discuss current status of vaccines against monkeypox in the US 

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-276-H01-P
Initial release date: 07/25/22
Expiration date: 07/25/2023
Additional CPE & CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram